CERO THERAPEUTICS HOLDINGS, INC.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

FY: Dec 31 2025

FY: Dec 31 2025

Q: Sep 30 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

FY: Dec 31 2024

FY: Dec 31 2024

Q: Sep 30 2024

Q: Sep 30 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

Q: Mar 31 2024

FY: Dec 31 2023

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Other Events

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Regulation FD Disclosure

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Entry into a Material Definitive Agreement

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Other Events

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Unregistered Sales of Equity Securities

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notification of removal from listing and/or registration on a national securities exchange

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

No description available

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Required Information in Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

No description available

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

No description available

Definitive Proxy Statement

Preliminary Proxy Statement

Tibbs Isaiah

Francois Eric

Francois Eric

Tibbs Isaiah

Byrnes Michael

Ehrlich Christopher B

Pierce Kristen

Patel Shami

LAPORTE KATHLEEN

KUCHARCHUK ANDREW ALBERT

Rolfe Lindsey

ATWOOD BRIAN G

ARMISTICE CAPITAL, LLC

Patel Shami

Byrnes Michael

Rolfe Lindsey

ATWOOD BRIAN G

KUCHARCHUK ANDREW ALBERT

Pierce Kristen

Ehrlich Christopher B

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC